Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06133751
Other study ID # SKaczmarczyk_PhD
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date April 1, 2023
Est. completion date June 10, 2023

Study information

Verified date October 2023
Source Poznan University of Physical Education
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Purpose: To analyze the effects of 8-week supplementation with anthocyanin compounds contained in black chokeberry (Aronia melanocarpa) on indicators of inflammation and oxidative stress. Hypothesis: Supplementation with anti-inflammatory and antioxidant anthocyanin compounds improves recovery from intense exercise by reducing inflammation and oxidative stress in highly trained rowers The study consisted of a nutritional intervention (supplementation) - with compounds of natural origin - chokeberry extract (capsules) - 18% standardized for anthocyanin content (dose 3 x 200 mg per day) - that is, 107 mg of pure anthocyanins per day, or a placebo product that was made from chokeberry fiber Study plan I term of the study 1. Conduct a body composition analysis, body height, food diary, self reported gastrointestinal scale 2. Collection of blood samples before the exercise test for biochemical determinations. 3. Exercise test of 2000m on a rowing ergometer. 4. Collection of blood immediately after exercise and 1 hours after 5. Collection of blood for biochemical determinations 24 hours after the end of the exercise test 6. Supplementation for 8 weeks 2nd test date Repeat the measurements from the 1st test date. Participants: Youth National Rowing Team of Poland Experimental procedure: Observation of the effect of black chokeberry consumption on parameters of inflammation, oxidative stress and intestinal parameters during the immediate start preparation period in highly skilled rowers.


Description:

Participants Twenty participants from the Youth National Rowing Team of Poland have been recruited for the study. In the end, fifteen rowers participated in the study (two did not show up for the first date, three more were absent for the second date). Before the first and second dates of the study, a body composition analysis was performed using the TANITA MC-780 with an accuracy of 0.05 kg, and hight was measured throughout sea 217 hightmeter. The experiment was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by the Ethical Committee of the Medical University of Poznan (resolution no. 390/22). All players were informed of the exact course of the study and gave written consent to participate. Youth National Rowing Team of Poland The athletes' diets were completely analyzed before each exercise test by a nutritionist. Participants, with the help of a dietician who was available during meals on test days, filled out food diaries. The amount of energy, protein, carbohydrates, fats and fiber were then analyzed using a commercially available program. Experimental procedure The rowers were randomly divided into two groups-supplemented and control, it was a double-blind study. Athletes in the supplemented group (n=7) consumed capsules with highly concentrated 18% chokeberry extract. One capsule contained 200 mg. In addition to chokeberry extract, each capsule also contained chokeberry fiber, E460b magnesium salts of stearic acid (anti-caking agent), E551 silicon dioxide (anti-caking agent), hydroxypropyl methylcellulose (capsule shell) and E171 titanium dioxide (shell color). The control group (n=8) consumed capsules that were made from chokeberry fiber. All additional substances the same as in capsules with chokeberry extract. The supplement and placebo product was manufactured by MBL BIOTRADE, Poznań. The rowers (both supplemented and control group) took 3 capsules a day (at breakfast, lunch and dinner) for 8 weeks. The athletes sipped each capsule with a glass of water. Exercise test On two testing dates (before and after supplementation), the athletes performed a 2,000-meter test on a rowing ergometer (Concept II, USA). Athletes had to complete the test in the shortest possible time overcoming the maximum load. The results of the test were taken into account in the selection for the championship team so the athletes performed the task with great motivation. Before the test, each competitor individually performed a 5-minute warm-up. Material collection and examination Samples were taken at three time points: pre (before the exercise test) post (immediately after the exercise test and 1 hour after) and recovery (24 hours after the exercise test) both before and after the supplementation period. Blood samples were collected from the elbow vein into 9-ml tubes (to obtain serum) and centrifuged at 3,000 rpm and into 2.7-ml tubes (to determine morphology). Morphology was determined on the same day the samples were collected, while serum was frozen and stored at -80oC until assays were performed. In addition, before and immediately after the exercise test, capillary blood was drawn from the earlobe to determine lactate levels. Measurements TAC (Total Antioxidant Capacity), TBARS (levels of lipid peroxidation products), IL-2, IL-6, IL-10, TNF-α and myoglobin levels were determined using ELISA kits (SunRed Biotechnology Company). Lactate levels were determined immediately after capillary blood sampling using a commercially available kit (Dr. Lange, Germany). The concentration of lactate was determined in mmol/l. intestinal parameters: LBP (lipopolysacharide-binding pro), Claudin3, I-FABP (intestinal fatty acid binding pro). After both tests, participants filled out self-reported gastrointestinal scale. Any data obtained during the research will be used only for the purposes of this research project. The participant has the right to access and correct his/her data, to obtain information regarding the processing of his/her personal data, to request the deletion or restriction of the processing of his/her data, the right to portability of the data provided, the right to object to the processing, and the right to withdraw consent to the processing of personal data at any time. Withdrawal of consent does not affect the lawfulness of processing carried out on the basis of consent before its withdrawal. The confidential nature of the research documentation will be respected throughout the study. Legal requirements for the protection of personal data will be observed. In the study documentation, participants will be identified by a nadem code at the beginning of the study. The results of this study will be published after pooled data analysis. Thus, the identity of the participants will remain confidential. The place of data storage is the university's branch office in Gorzow Wielkopolski. All parameters will be analyzed using Elisamtests and read on the ELISAMAR reader. In terms of statistical measures, the following will be performed: descriptive statistics, Shapiro-Wilk test to assess normality, and multivariate analysis of variance ANOVA test.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date June 10, 2023
Est. primary completion date June 10, 2023
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 24 Years
Eligibility Inclusion Criteria: - Training experience a minimum of five years - Minimum training time per week 240 minute - Membership in the Youth National Rowing Team of Poland - Completion of the 2000m ergometer test on two test dates Exclusion Criteria: - Taking other supplements containing anthocyanin compounds during the study period or a month earlier - Antibiotic therapy - Health problems

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
black chokeberry (Aronia melanocarpa)
Black chokeberry capsules standardized for anthocyanin compounds
Placebo
Chokeberry fiber placebo capsules

Locations

Country Name City State
Poland University of Physical Education in Poznan Poznan

Sponsors (1)

Lead Sponsor Collaborator
Poznan University of Physical Education

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Level of total antioxidants (TAC) ELISA kits (SunRed Biotechnology Company) - Indicators of pro-oxidant-antioxidant balance 8 weeks
Primary interleukins: IL-2, IL-6, IL-10 ELISA kits (SunRed Biotechnology Company) - Immunological indicators 8 weeks
Primary lactic acid Diaglobal, Berlin, Germany) 8 weeks
Primary LBP (lipopolysacharide-binding pro) ELISA kits (SunRed Biotechnology Company) - Gut parameter 8 weeks
Primary level of lipid peroxidation products (TBARS) ELISA kits (SunRed Biotechnology Company) - Indicators of pro-oxidant-antioxidant balance 8 weeks
Primary (NO) nitric oxide obtained by indirect method Griessa - Indicators of pro-oxidant-antioxidant balance 8 weeks
Primary comet assay (DNA damage) comet assay BioTechne 8 weeks
Primary tumor necrosis factor (TNF a) ELISA kits (SunRed Biotechnology Company) - Immunological indicators 8 weeks
Primary myoglobin ELISA kits (SunRed Biotechnology Company) 8 weeks
Primary I-FABP (intestinal fatty acid binding protein) ELISA kits (SunRed Biotechnology Company) - Gut parameter 8 weeks
Primary Claudin3 ELISA kits (SunRed Biotechnology Company) - Gut parameter 8 weeks
Secondary gastrointestinal symptom scale Self-reported 10-point scale, 10 is the most severe symptoms on the scale 8 weeks
Secondary energy [kcal] dietitian program 8 weeks
Secondary protein [g] dietitian program 8 weeks
Secondary fat [g] dietitian program 8 weeks
Secondary carbohydrate [g] dietitian program 8 weeks
Secondary fiber [g] dietitian program 8 weeks
Secondary body hight [m] secco 217 highmeter 8 weeks
Secondary body mass [kg] body analyzer 8 weeks
Secondary body fat [%,kg] body analyzer 8 weeks
Secondary total body water [%,kg] body analyzer 8 weeks
Secondary lean body mass [kg] body analyzer 8 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04565821 - Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe N/A
Recruiting NCT06392360 - Betaine, Exercise Performance, and Gut Permeability N/A
Recruiting NCT03434639 - Fluorescence Spectroscopy for Gut Permeability Assessment
Completed NCT04046289 - Effects of Probiotics and Calcium Supplementation on Growth, Development, and Metabolic Parameters
Completed NCT03408691 - PRObiotic and Stress-related PERmeability N/A
Recruiting NCT05477212 - Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet. N/A
Completed NCT02021253 - Influence of Probiotics Administration Before Liver Resection in Liver Disease N/A